Literature DB >> 8041783

Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors.

C Garlanda1, C Parravicini, M Sironi, M De Rossi, R Wainstok de Calmanovici, F Carozzi, F Bussolino, F Colotta, A Mantovani, A Vecchi.   

Abstract

A retroviral construct encoding polyoma middle-sized T antigen was used to generate transformed endothelial cell lines from heart (H5V), brain (B9V), and whole-embryo (E10V) of C57BL/6 mice. When injected into syngeneic recipients, H5V and the less studied B9V and E10V cells caused vascular tumors which, depending on the number of cells inoculated, regressed or progressed, leading to death of the host. When H5V cells were injected into immunodeficient mice, tumors were observed with inocula which did not form lesions in immunocompetent recipients and regression did not occur. Treatment with anti-LFA-1, anti-Thy-1.2, and anti-CD8 antibodies abolished rejection; anti-CD4 was a somewhat less effective inhibitor of resistance. Animals with progressive tumors exhibited secondary lesions in various organs with prominent skin involvement in nude mice. Histologically, the tumors had the appearance of a hemangioma, with areas resembling Kaposi sarcoma. Cells lining vascular lacunae had the morphological features of injected H5V cells. The lesions were characterized by prominent neovascularization and mononuclear cell infiltration. Southern blot hybridization analysis revealed that approximately 5% of the cells in the tumor mass were transplanted H5V cells. Thus, the H5V transformed endothelial line causes vascular lesions that are sustained to a large extent by recruitment of host cells and manifests full malignant behavior only in immunocompromised hosts. The hypothesis of a tumor sustained by a minute proportion of transformed cells, which recruit host elements and express full malignant behavior only in immunodeficient hosts, would account for several features of some vascular neoplasms in man.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8041783      PMCID: PMC44385          DOI: 10.1073/pnas.91.15.7291

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Cytokine regulation of endothelial cell function.

Authors:  A Mantovani; F Bussolino; E Dejana
Journal:  FASEB J       Date:  1992-05       Impact factor: 5.191

2.  Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene.

Authors:  R L Williams; S A Courtneidge; E F Wagner
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

3.  Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

Authors:  S Nakamura; S Z Salahuddin; P Biberfeld; B Ensoli; P D Markham; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

4.  Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium.

Authors:  A Vecchi; C Garlanda; M G Lampugnani; M Resnati; C Matteucci; A Stoppacciaro; H Schnurch; W Risau; L Ruco; A Mantovani
Journal:  Eur J Cell Biol       Date:  1994-04       Impact factor: 4.492

5.  Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene.

Authors:  G Taraboletti; D Belotti; E Dejana; A Mantovani; R Giavazzi
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

6.  Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.

Authors:  A Rambaldi; M Terao; S Bettoni; R Bassan; R Battista; T Barbui; E Garattini
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

7.  Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Authors:  R A Ezekowitz; J B Mulliken; J Folkman
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

8.  Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

Authors:  S Z Salahuddin; S Nakamura; P Biberfeld; M H Kaplan; P D Markham; L Larsson; R C Gallo
Journal:  Science       Date:  1988-10-21       Impact factor: 47.728

9.  AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

Authors:  B Ensoli; S Nakamura; S Z Salahuddin; P Biberfeld; L Larsson; B Beaver; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1989-01-13       Impact factor: 47.728

10.  T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.

Authors:  A DiGiacomo; R J North
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  56 in total

1.  Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration.

Authors:  G Condorelli; U Borello; L De Angelis; M Latronico; D Sirabella; M Coletta; R Galli; G Balconi; A Follenzi; G Frati; M G Cusella De Angelis; L Gioglio; S Amuchastegui; L Adorini; L Naldini; A Vescovi; E Dejana; G Cossu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

2.  Epigenetic control of hypoxia inducible factor-1α-dependent expression of placental growth factor in hypoxic conditions.

Authors:  Laura Tudisco; Floriana Della Ragione; Valeria Tarallo; Ivana Apicella; Maurizio D'Esposito; Maria Rosaria Matarazzo; Sandro De Falco
Journal:  Epigenetics       Date:  2014-02-06       Impact factor: 4.528

3.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

4.  VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2.

Authors:  Alexandra Le Bras; Chantal Samson; Matteo Trentini; Bertrand Caetano; Etienne Lelievre; Virginie Mattot; Friedrich Beermann; Fabrice Soncin
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

5.  Eicosapentaenoic acid inhibits endothelial cell migration in vitro.

Authors:  Laura Tonutti; Luca Manzi; Maria T Tacconi; Gianfranco Bazzoni
Journal:  J Angiogenes Res       Date:  2010-07-09

6.  Intimal cushions and endothelial nuclear elongation around mouse aortic branches and their spatial correspondence with patterns of lipid deposition.

Authors:  Andrew R Bond; Chih-Wen Ni; Hanjoong Jo; Peter D Weinberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

7.  Isolation and molecular characterization of a mouse renal microvascular endothelial cell line.

Authors:  Silvina Gazzaniga; Lorena González; Alberto Mantovani; Annunciata Vecchi; Rosa Wainstok
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Mar-Apr       Impact factor: 2.416

8.  Spatial and temporal regulation of coronary vessel formation by calcineurin-NFAT signaling.

Authors:  Miriam Zeini; Calvin T Hang; Joshua Lehrer-Graiwer; Tiffany Dao; Bin Zhou; Ching-Pin Chang
Journal:  Development       Date:  2009-08-26       Impact factor: 6.868

9.  Angiogenesis in platelet endothelial cell adhesion molecule-1-null mice.

Authors:  Gaoyuan Cao; Melane L Fehrenbach; James T Williams; Jeffrey M Finklestein; Jing-Xu Zhu; Horace M Delisser
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

10.  Mouse tumor vasculature expresses NKG2D ligands and can be targeted by chimeric NKG2D-modified T cells.

Authors:  Tong Zhang; Charles L Sentman
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.